A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI

Pathophysiology

Volumn 20, Issue 1, 2013, Pages 39-48

  Wagner, Amy K ^a,b,c   Zitelli, Kevin T ^a  

^a Department of Physical Medicine and Rehabilitation ^*  (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Depression; Hypogonadism; Pathophysiology; Recovery; Rehabilomics; Seizures; TBI

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; DOPAMINE; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEURON SPECIFIC ENOLASE; NORADRENALIN; PROTEIN S100B; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN DEGENERATION; CONVALESCENCE; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HYPOGONADISM; MOLECULAR MECHANICS; NERVE CELL INHIBITION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; REHABILITATION MEDICINE; REHABILOMICS; SEIZURE; TISSUE DEGENERATION; TRAUMATIC BRAIN INJURY;

EID: 84878209604     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.02.007     Document Type: Article

References (128)

1. Wagner A.K., Arenth P.M., Kwasnica C., Rogers E.H. Traumatic brain injury. Physical Medicine & Rehabilitation 2010, 1133-1176. Elsevier, Amsterdam. 4th ed. R.L. Braddom (Ed.).
2. Faul M., Xu L., Wald M.M., Coronado V.G. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths 2002-2006 2010.
3. Pfizer Facts The Health Status of the United States Army: Findings from the Total Army Injury and Health Outcomes Database (TAIHOD) 2003.
4. Berger R.P. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. Head Trauma Rehabil. 2006, 21:315-333.
5. Wagner A.K. Translational rehabilitation research in the 21st century: exploring a rehabilomics research model. Eur. J. Phys. Rehabil. Med. 2010, 46:549-556.
6. Wagner A.K. Rehabilomics: a conceptual framework to drive biologics research. PM R 2011, 3:28-30.
7. Gennarelli T.A., Meaney D.F. Mechanisms of primary head injury. Neurosurgery 1996, McGraw-Hill, New York. R.H. Wilkins, S.S. Rengacharym (Eds.).
8. Ommaya A.K., Grubb R.L., Naumann R.A. Coup and contre-coup injury: observations on the mechanics of visible brain injuries in the rhesus monkey. J. Neurosurg. 1971, 35:503-516.
9. Halliday A.L. Pathophysiology. Traumatic Brain Injury 1999, Thieme Medical Publishers Inc., New York. W. Donald, Marion (Eds.).
10. Bullock R. Excitatory amino acids following brain injury. J. Neurosurg. 1994, 80:595-596.
11. Wagner A.K., Fabio A., Puccio A.M. Gender associations with cerebrospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Crit. Care Med. 2005, 33:407-413.
12. Sugiyama H., Ito I., Hirono C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature 1987, 325:531-533.
13. Choi D.W. Ionic dependence of glutamate toxicity. J. Neurosci. 1987, 7:369-379.
14. Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999, 9:119-131.
15. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7915-7922.
16. Bayir H., Marion D.W., Puccio A.M., Wisniewski S.R., Janesko K.L., Clark R.S., Kochanek P.M. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J. Neurotrauma 2004, 21:1-8.
17. Wagner A.K., Bayir H., Ren D., Puccio A., et al. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. Neurotrauma 2004, 21:125-136.
18. Fink K.B., Andrews L.J., Butler W.E., Ona V.O., Li M., Bogdanov M., Endres M., Khan S.Q., Namura S., Stieg P.E., Beal M.F., Moskowitz M.A., Yuan J., Friedlander R.M. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 1999, 94:1213-1218.
19. Clark R.S., Kochanek P.M., Watkins S.C., Chen M., Dixon C.E., Seidberg N.A., Melick J., Loeffert J.E., Nathaniel P.D., Jin K.L., Graham S.H. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J. Neurochem. 2000, 74:740-753.
20. Zhang X., Graham S.H., Kochanek P.M., Marion D.W., Nathaniel P.D., Watkins S.C., Clark R.S. Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J. 2003, 17:1367-1369.
21. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.
22. Buttram S.D., Wisniewski S.R., Jackson E.K., Adelson P.D., Feldman K., Bayir H., Berger R.P., Clark R.S., Kochanek P.M. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J. Neurotrauma 2007, 24:1707-1717.
23. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2011, 31:658-670.
24. Frugier T., Morganti-Kossmann M.C., O'Reilly D., McLean C.A. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J. Neurotrauma 2010, 27:497-507.
25. Bell M.J., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S., Dixon C.E., Marion D.W., Jackson E. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma 1998, 15:163-170.
26. Wagner A.K., Amin K., Niyonkuru C., Postal B.A., McCullough E.H., Ozawa H., Bayir H., Clark R.S., Kochanek P.M., Fabio A. CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J. Cereb. Blood Flow Metab. 2011, 31(9):1886-1896.
27. Clark R.S., Kochanek P.M., Adelson P.D., Bell M.J., Carcillo J.A., Chen M., Wisniewski S.R., Janesko K., Whalen M.J., Graham S.H. Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. J. Pediatr. 2000, 137:197-204.
28. Hoh N.Z., Wagner A.K., Alexander S.A., Clark R.B., Beers S.R., Okonkwo D.O., Ren D., Conley Y.P. BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury. J. Neurotrauma 2010, 27:1413-1427.
29. Stein D.G., Cekic M.M. Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PM R 2011, 3:S100-S110.
30. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin. Investig. Drugs 2010, 19:847-857.
31. Herson P.S., Koerner I.P., Hurn P.D. Sex, sex steroids, and brain injury. Semin. Reprod. Med. 2009, 27:229-239.
32. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402.
33. Wagner A.K., McCullough E.H., Niyonkuru C., Ozawa H., Loucks T., Dobos J.A., Brett C.A., Dixon C.E., Berga S., Fabio A. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J. Neurotrauma 2011, 28(6):871-888.
34. Dossett L.A., Swenson B.R., Evans H.L., Bonatti H., Sawyer R.G. Serum estradiol concentration as a predictor of death in critically ill and injured adults. Surg. Infect. (Larchmt.) 2008, 9:41-48.
35. Dossett L.A., Swenson B.R., Heffernan D., Bonatti H., Metzger R., Sawyer R.G., May A.K. High levels of endogenous estrogens are associated with death in the critically injured adult. J. Trauma 2008, 64:580-585.
36. Spratt D.I., Morton J.R., Kramer R.S., Mayo S.W., Longcope C., Vary C.P., Spratt D.I., Morton J.R., Kramer R.S., Mayo S.W., Longcope C., Vary C.P.H. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am. J. Physiol.: Endocrinol. Metab. 2006, 291:E631-E638.
37. Rogers E., Postal B.A., Fabio A., Yuan Z., Loucks T., Berga S., Wagner A.K. Serum and cerebrospinal fluid hormone levels in a population with severe traumatic brain injury. J. Neurotrauma 2007, 24(7):1244.
38. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., Cottingham R., Svoboda P., Brayley N., Mazairac G., Laloe V., Munoz-Sanchez A., Arango M., Hartzenberg B., Khamis H., Yutthakasemsunt S., Komolafe E., Olldashi F., Yadav Y., Murillo-Cabezas F., Shakur H., Edwards P., Crash t.c. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
39. Berger R.P., Kochanek P.M., Pierce M.C. Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury?. Child Abuse Negl. 2004, 28:739-754.
40. Berger R.P., Adelson P.D., Richichi R., Kochanek P.M. Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev. Neurosci. 2006, 28:327-335.
41. Shore P.M., Berger R.P., Varma S., Janesko K.L., Wisniewski S.R., Clark R.S., Adelson P.D., Thomas N.J., Lai Y.C., Bayir H., Kachanek P.M. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury. J. Neurotrauma 2007, 24:75-86.
42. Garman R.H., Jenkins L.W., Switzer R.C., Bauman R.A., Tong L.C., Swauger P.V., Parks S.A., Ritzel D.V., Dixon C.E., Clark R.S., Bayir H., Kagan V., Jackson E.K., Kochanek P.M. Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. J. Neurotrauma 2011, 28:947-959.
43. Bauman R.A., Ling G., Tong L., Januszkiewicz A., Agoston D., Delanerolle N., Kim Y., Ritzel D., Bell R., Ecklund J., Armonda R., Bandak F., Parks S. An introductory characterization of a combat-casualty-care relevant swine model of closed head injury resulting from exposure to explosive blast. J. Neurotrauma 2009, 26:841-860.
44. Blyth B., Farahvar A., He H., Nayak A., Yang C., Shaw G., Bazarian J.J. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood brain barrier function after traumatic brain injury. J. Neurotrauma 2011.
45. Morita-Fujimura Y., Fujimura M., Kawase M., Chen S.F., Chan P.H. Release of mitochondrial cytochrome C and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis. Neurosci. Lett. 1999, 267:201-205.
46. Kochanek P.M., Berger R.P., Bayir H., Wagner A.K., Jenkins L.W., Clark R.S. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 2008, 14:135-141.
47. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
48. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., Mucke L., Johnson M.H., Sofroniew M.V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23:297-308.
49. Smith D.H., Chen X.H., Pierce J.E., Wolf J.A., Trojanowski J.Q., Graham D.I., McIntosh T.K. Progressive atrophy and neuron death for one year following brain trauma in the rat. J. Neurotrauma 1997, 14:715-727.
50. Dixon C.E., Kochanek P.M., Yan H.Q., Schiding J.K., Griffith R.G., Baum E., Marion D.W., DeKosky S.T. One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J. Neurotrauma 1999, 16:109-122.
51. Bigler E.D., Maxwell W.L. Neuroimaging and neuropathology of TBI. NeuroRehabilitation 2011, 28:63-74.
52. Messori A., Polonara G., Carle F., Gesuita R., Salvolini U. Predicting posttraumatic epilepsy with MRI: prospective longitudinal morphologic study in adults. Epilepsia 2005, 46:1472-1481.
53. Wetherington J., Serrano G., Dingledine R. Astrocytes in the epileptic brain. Neuron 2008, 58:168-178.
54. Sandhaug M., Andelic N., Vatne A., Seiler S., Mygland A. Functional level during sub-acute rehabilitation after traumatic brain injury: course and predictors of outcome. Brain Inj. 2010, 24:740-747.
55. Masel B.E., DeWitt D.S. Traumatic brain injury: a disease process, not an event. J. Neurotrauma 2010, 27:1529-1540.
56. Johnson V.E., Stewart W., Smith D.H. Traumatic brain injury and amyloid-ß pathology: a link to Alzheimer's disease?. Nature 2010.
57. Ikonomovic M.D., Uryu K., Abrahamson E.E., Ciallella J.R., Trojanowski J.Q., Lee V.M., Clark R.S., Marion D.W., Wisniewski S.R., DeKosky S.T. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 2004, 190:192-203.
58. Johnson V.E., Stewart W., Smith D.H. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2011.
59. Omalu B., Bailes J., Hamilton R.L., Kamboh M.I., Hammers J., Case M., Fitzsimmons R.J. Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery 2011, 69:173-183.
60. Conley Y.P., Alexander S. Genomic, transcriptomic, and epigenomic approaches to recovery after acquired brain injury. PM R 2011, 3:S52-S58.
61. McAllister T.W. Genetic factors modulating outcome after neurotrauma. PM R 2010, 2:S241-S252.
62. Su E., Bell M.J., Wisniewski S.R., Adelson P.D., Janesko-Feldman K.L., Salonia R., Clark R.S., Kochanek P.M., Kagan V.E., Bayir H. alpha-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev. Neurosci. 2010, 32:385-395.
63. Urrea C., Castellanos D.A., Sagen J., Tsoulfas P., Bramlett H.M., Dietrich W.D. Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat. Restor. Neurol. Neurosci. 2007, 25:65-76.
64. Kleim J.A., Barbay S., Cooper N.R., Hogg T.M., Reidel C.N., Remple M.S., Nudo R.J. Motor learning-dependent synaptogenesis is localized to functionally reorganized motor cortex. Neurobiol. Learn. Mem. 2002, 77:63-77.
65. Nishibe M., Barbay S., Guggenmos D., Nudo R.J. Reorganization of motor cortex after controlled cortical impact in rats and implications for functional recovery. J. Neurotrauma 2010, 27:2221-2232.
66. Queen S.A., Chen M.J., Feeney D.M. d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res. 1997, 777:42-50.
67. Nudo R.J. Adaptive plasticity in motor cortex: implications for rehabilitation after brain injury. J. Rehabil. Med. 2003, 7-10.
68. Kolb B., Gibb R. Brain plasticity and recovery from early cortical injury. Dev. Psychobiol. 2007, 49:107-118.
69. Kolb B., Teskey G.C., Gibb R. Factors influencing cerebral plasticity in the normal and injured brain. Front Hum. Neurosci. 2010, 4:204.
70. Whyte J., Hart T., Vaccaro M., Grieb-Neff P., Risser A., Polansky M., Coslett H.B. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am. J. Phys. Med. Rehabil. 2004, 83:401-420.
71. Goldstein L.B. Neuropharmacology of TBI-induced plasticity. Brain Inj. 2003, 17:685-694.
72. Gorman L.K., Fu K., Hovda D.A., Becker D.P., Katayama Y. Analysis of acetylcholine release following concussive brain injury in the rat. J. Neurotrauma 1989, 6:203.
73. Dixon C.E., Bao J., Johnson K.M., Yang K., Whitson J., Clifton G.L., Hayes R.L. Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci. Lett. 1995, 198:111-114.
74. Dixon C.E., Bao J., Bergmann J.S., Johnson K.M. Traumatic brain injury reduces hippocampal high-affinity [3H]choline uptake but not extracellular choline levels in rats. Neurosci. Lett. 1994, 180:127-130.
75. Gorman L.K., Fu K., Hovda D.A., Murray M., Traystman R.J. Effects of traumatic brain injury on the cholinergic system in the rat. J. Neurotrauma 1996, 13:457-463.
76. Cohen J.D., Servan-Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol. Rev. 1992, 99:45-77.
77. Floresco S.B., Magyar O. Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl.) 2006, 188:567-585.
78. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990, 13:266-271.
79. Massucci J.L., Kline A.E., Ma X., Zafonte R.D., Dixon C.E. Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci. Lett. 2004, 372:127-131.
80. McIntosh T.K., Yu T., Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 1994, 63:1426-1433.
81. Wagner A.K., Chen X., Kline A.E., Li Y., Zafonte R.D., Dixon C.E. Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp. Neurol. 2005, 195:475-483.
82. Yan H.Q., Kline A.E., Ma X., Hooghe-Peters E.L., Marion D.W., Dixon C.E. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. Neuroreport 2001, 12:2323-2327.
83. Wagner A.K., Drewencki L.L., Chen X., Santos F.R., Khan A.S., Harun R., Torres G.E., Michael A.C., Dixon C.E. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J. Neurochem. 2009, 108:986-997.
84. Shin S.S., Bray E.R., Zhang C.Q., Dixon C.E. Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats. Brain Res. 2011, 19(1369):208-215.
85. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 1998, 18:2697-2708.
86. Kline A.E., Yan H.Q., Bao J., Marion D.W., Dixon C.E. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 2000, 280:163-166.
87. Becker J.B., Rudick C.N. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 1999, 64:53-57.
88. Peris J., Decambre N., Coleman-Hardee M.L., Simpkins J.W. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res. 1991, 566:255-264.
89. Hamm R.J., Temple M.D., O'Dell D.M., Pike B.R., Lyeth B.G. Exposure to environmental complexity promotes recovery of cognitive function after traumatic brain injury. J. Neurotrauma 1996, 13:41-47.
90. Wagner A.K., Kline A.E., Sokoloski J., Zafonte R.D., Capulong E., Dixon C.E. Intervention with environmental enrichment after experimental brain trauma enhances cognitive recovery in male but not female rats. Neurosci. Lett. 2002, 334:165-168.
91. Wagner A.K., Sokoloski J.E., Chen X., Harun R., Clossin D.P., Khan A.S., Andes-Koback M., Michael A.C., Dixon C.E. Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission. J. Neurochem. 2009, 110:801-810.
92. Goldstein L.B., Bullman S. Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury. Pharmacol. Biochem. Behav. 1997, 58:1151-1157.
93. Goldstein L.B., Coviello A., Miller G.D., Davis J.N. Norepinephrine depletion impairs motor recovery following sensorimotor cortex injury in the rat. Restor. Neurol. Neurosci. 1991, 3:41-47.
94. Boyeson M.G., Feeney D.M. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol. Biochem. Behav. 1990, 35:497-501.
95. Wilson M.S., Hamm R.J. Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats. Am. J. Phys. Med. Rehabil. 2002, 81:364-372.
96. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 1999, 23:1111-1125.
97. Cheng J.P., Aslam H.A., Hoffman A.N., Zafonte R.D., Kline A.E. The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window. Neurosci. Lett. 2007, 416:165-168.
98. Cheng J.P., Hoffman A.N., Zafonte R.D., Kline A.E. A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning. Behav. Brain Res. 2008, 194(1):79-85.
99. Wang Y., Neumann M., Hansen K., Hong S.M., Kim S., Noble-Haeusslein L.J., Liu J. Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J. Neurotrauma 2011, 28:259-268.
100. Meythaler J.M., Depalma L., Devivo M.J., Guin-Renfroe S., Novack T.A. Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj. 2001, 15:321-331.
101. Cernak I., Savic V.J., Lazarov A., Joksimovic M., Markovic S. Neuroendocrine responses following graded traumatic brain injury in male adults. Brain Inj. 1999, 13:1005-1015.
102. A.K. Wagner, C.A. Brett, E.H. McCullough, C. Niyonkuru, T. Loucks, P.M. Arenth, J.H. Ricker, S. Berga, Persistent Hypogonadism influences estrogen synthesis, cognition and outcome in males after severe TBI, Brain Inj. (2012), in press.
103. Spencer J.L, Waters E.M., Romeo R.D., Wood G.E., Milner T.A., McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front. Neuroendocrinol. 2008, 29:219-237.
104. McEwen B.S. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann. N. Y. Acad. Sci. 2010, 1204(Suppl.):E38-E59.
105. Englander J., Bushnik T., Duong T.T., Cifu D.X., Zafonte R., Wright J., Hughes R., Bergman W. Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation. Arch. Phys. Med. Rehabil. 2003, 84:365-373.
106. Dikmen S.S., Temkin N.R., Miller B., Machamer J., Winn H.R. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991, 265:1271-1277.
107. Swartz B.E., Houser C.R., Tomiyasu U., Walsh G.O., DeSalles A., Rich J.R., Delgado-Escueta A. Hippocampal cell loss in posttraumatic human epilepsy. Epilepsia 2006, 47:1373-1382.
108. Raymont V., Salazar A.M., Lipsky R., Goldman D., Tasick G., Grafman J. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology 2010, 20(75):224-229.
109. Kochanek P.M., Vagni V.A., Janesko K.L., Washington C.B., Crumrine P.K., Garman R.H., Jenkins L.W., Clark R.S., Homanics G.E., Dixon C.E., Schnermann J., Jackson E.K. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 2006, 26:565-575.
110. Binder D.K., Steinhauser C. Functional changes in astroglial cells in epilepsy. Glia 2006, 54:358-368.
111. Lukasiuk K., Dabrowski M., Adach A., Pitkanen A. Epileptogenesis-related genes revisited. Prog. Brain Res. 2006, 158:223-241.
112. Fedele D.E., Gouder N., Guttinger M., Gabernet L., Scheurer L., Rulicke T., Crestani F., Boison D. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain 2005, 128:2383-2395.
113. Annegers J.F., Hauser W.A., Coan S.P., Rocca W.A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 1998, 338:20-24.
114. Wagner A.K., Miller M.A., Scanlon J., Ren D., Kochanek P.M., Conley Y.P. Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. Epilepsy Res. 2010, 90:259-272.
115. Darrah S., Miller M.A., Scanlon J.A., Conley Y.P., Wagner A.K. Modeling genetic susceptibility to seizures after TBI. Am. J. Phys. Med. Rehabil. 2010, 89(4). Supplement S6.
116. Bombardier C.H., Fann J.R., Temkin N.R., Esselman P.C., Barber J., Dikmen S.S. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA 2010, 303(19):1938-1945.
117. Lee H., Kim S.W., Kim J.M., Shin I.S., Yang S.J., Yoon J.S. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum. Psychopharmacol. 2005, 20:97-104.
118. Warden D.L., Gordon B., McAllister T.W., Silver J.M., Barth J.T., Bruns J., Drake A., Gentry T., Jagoda A., Katz D.I., Kraus J., Labbate L.A., Ryan L.M., Sparling M.B., Walters B., Whyte J., Zapata A., Zitnay G. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J. Neurotrauma 2006, 23:1468-1501.
119. Mahesh R., Pandey D.K., Katiyar S., Kukade G., Viyogi S., Rudra A. Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian J. Exp. Biol. 2010, 48:466-473.
120. Fann J.R., Hart T., Schomer K.G. Treatment for depression after traumatic brain injury: a systematic review. J. Neurotrauma 2009, 26:2383-2402.
121. Lanctot K.L., Rapoport M.J., Chan F., Rajaram R.D., Strauss J., Sicard T., McCullagh S., Feinstein A., Kiss A., Kennedy J.L., Bassett A.S., Herrmann N. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj. 2010, 24:959-969.
122. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
123. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
124. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 1997, 56:131-137.
125. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
126. Carter M.D., Miller M.A., Burkhardt J.N., Scanlon J.M., Ferrell R., Conley Y.P., Wagner A.K. Variants of SLC6A4 and BDNF in depression risk and onset following severe TBI. J. Neurotrauma 2011, 28:A-14.
127. Miller M.A., Carter M., Scanlon J.M., Ferrell R., Conley Y.P., Arenth P., Wagner A.K. COMT gene variant associations with depression, cognition, and recovery after severe TBI. J. Neurotrauma 2011, 28:A-100.
128. Garringer J., Wagner A.K. Impact of Aromatase genetic variation on hormone levels and functional outcome after TBI. Am. J. Phys. Med. Rehabil. 2010, 89(4). Supplement S6.